Meyerson's phenomenon in a patient affected by high-risk melanoma under treatment with interferon-α

Melanoma Res. 2012 Jun;22(3):284-5. doi: 10.1097/CMR.0b013e3283541563.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • Adult
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Drug Eruptions / etiology*
  • Drug Eruptions / immunology
  • Drug Eruptions / pathology
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage
  • Interferon-alpha / adverse effects*
  • Lymphatic Metastasis
  • Male
  • Melanoma / drug therapy*
  • Melanoma / immunology
  • Melanoma / secondary
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / adverse effects
  • Skin / drug effects*
  • Skin / immunology
  • Skin / pathology
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / immunology
  • Skin Neoplasms / pathology
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins